Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Developed by researchers in Australia, AOD-9604 was initially investigated as a potential anti-obesity drug due to its ability to stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat accumulation)
It uses advanced diagnostics to uncover early signs of metabolic slowdown, hormonal shifts, inflammation, cardiovascular risk, and cellular aging
The contents of other metabolites in feces were all lower than 0.06% of the administered amount, and it was impossible to perform structural identification because of the extremely low content
Its stability in gastric acid also makes it orally active, a rarity among peptides
Bacteriostatic Water and BPC-157 In addition to BPC-157, researchers will need to have the right supplies on hand for proper peptide handling
US$ 22.17
:max_bytes(150000):strip_icc()/VWH.GettyImages-2210289455-1dedbe07d04f4da0bd4d5046ce32bec6.jpg)
US$ 27.17
US$ 28.35
US$ 29.59
